As one of the few dentists commissioned to administer these saliva diagnostic tests, Dr. McClatchie is proud to be a practitioner of the OralDNA process. Understanding the association between oral health and systemic health provides exciting opportunities today for the dental and medical communities to reframe protocols and initiate cross-referrals. At Dr. McClatchie’s dental practice, we pride ourselves on practicing “oral medicine” and focusing on an overall wellness model. We execute a thorough comprehensive oral assessment, head and neck examination, radiographs (when clinically indicated), periodontal probing and carious lesion detection.
In an effort to make a more informed and objective diagnosis of patients with periodontal disease, Dr. McClatchie has incorporated two salivary diagnostic (DNA) tests – MyPerioPath and MyPerioID PST. The methodical application of this approach is paramount to providing the best treatment to patients. As these assessments are being performed, Dr. McClatchie’s team of registered dental hygienists notes any risk factors for oral and systemic diseases the patient presents with and thoroughly explains the correlations to the patients. Her team can then organize a profile that includes oral and systemic risk factor findings and discuss how their chronic (reversible) gingivitis or (irreversible) periodontal disease may place them at risk for cardiovascular disease
, poor glycemic control, rheumatoid arthritis, respiratory complications, stroke, poor nutrition, pre-term delivery and even adverse pregnancy outcomes.
Because of the important correlations between oral and whole-body health, Dr. McClatchie would like you to know how honored she would be to assist in any way she can, including performing oral health assessments. We will gladly conduct a MyPerioPath and/or MyPerioID PST for anyone who may have a systemic health risk or condition such as those stated above. Information gained from these two tests allows Dr. McClatchie to treat the individual patient more effectively, which may have a positive influence on whole-body wellness. Test results provide information on the type and concentration of the disease-causing bacteria, a patient specific bacterial-related risk of disease progression and suggestions for suitable therapy. A salivary diagnostic test will identify whether the patient has a genetic predisposition to an over exaggerated response to inflammation, resulting in a greater risk for periodontal disease and systemic inflammation.
To learn more about this testing, feel free to contact us or visit www.oraldna.com.
Patient X presented of moderate periodontal disease with severe bleeding, inflammation, bone loss, discoloration, and concerning pocket depths.
Step 1: Preliminary OralDNA screening
Step 2: Scaling and Root Planing, placement of localized antibiotic and prescription of bacterial specific antibiotic
Step 3: Post-OralDNA test and 3 month periodontal therapy
Figure illustrates bacteria levels prior to therapy compared to post therapy (Click to enlarge)
Figure illustrates a high risk patient with Interleukin 6, an inflammatory hormone (Click to enlarge)
Figure illustrates what systemic conditions are affected by adjacent bacteria (Click to enlarge)
Dr. McClatchie’s office uses clinical laboratory services from OralDNA LabsTM to ensure they are giving their patients the best oral health information possible. OralDNA LabsTMTM is a specialty diagnostics company designed to provide reliable, definitive and cost effective clinical tests that guide oral health professionals in detecting and prognosing disease at an earlier, more treatable stage.